Bio Nova’s tissue-engineering process allows almost unlimited design flexibility in terms of both the material and the three dimensional form.

By careful control of the tissue building processes, Bio Nova is able to tailor the properties and architecture of its engineered tissues to meet specific medical applications.

Bio Nova has also developed methods to grow a variety of human cells on its tissue scaffolds prior to implant into the patient. The result is a range of unique biomaterials that cannot be produced by any other method and which provide many of the desired matrix properties for tissue engineering.

Key projects include development of:

• Coronary artery bypass graft (CABG)
• Anterior cruciate ligament (ACL) prosthesis